Arch Gen Psychiatry:基底细胞癌风险与早期生活压力有关

2012-06-17 Beyond 生物谷

早期生活陷入亲子关系困境的人在过去一年有严重生活困扰的话可能会罹患一种最常见的皮肤癌——基底细胞癌(BCC)。这项研究发表在Archives of General Psychiatry杂志上。 文章背景资料指出,压力事件和由此产生的负面情绪可以引发人体的免疫系统功能障碍,带来临床症状的重大变化,影响基底细胞癌以及病情的发展。童年暴晒于太阳下,白皙的皮肤类型和男性性别是基底细胞癌的第一危险因素,但

早期生活陷入亲子关系困境的人在过去一年有严重生活困扰的话可能会罹患一种最常见的皮肤癌——基底细胞癌(BCC)。这项研究发表在Archives of General Psychiatry杂志上。

文章背景资料指出,压力事件和由此产生的负面情绪可以引发人体的免疫系统功能障碍,带来临床症状的重大变化,影响基底细胞癌以及病情的发展。童年暴晒于太阳下,白皙的皮肤类型和男性性别是基底细胞癌的第一危险因素,但研究人员强调但其该类型实肿瘤不只与这些危险因素有关。

基底细胞癌患者体内免疫系统对肿瘤细胞起着负面突出作用,因为肿瘤细胞具有免疫原性,基底细胞癌不像其他许多常见的癌症,不会表现出同样的免疫系统反应,同时研究还发现患者心里压力可能对肿瘤的发生发展也发挥重要作用。

哥伦布俄亥俄州州立大学医学中心Christopher P. Fagundes博士他的团队考察了48男和43女,年龄在23岁至92岁之间的人,这些人早期都患有基底细胞癌,研究人员评估了这些人及其子女的最近生活状况、抑郁症和mRNA(信使RNA)的情况。

我们的研究结果表明基底细胞癌患者在过去一年中经历了严重的应激,那些经历母亲或父亲的情感虐待的孩子更可能有较差的免疫反应,表现为CD2 5、CD3ε、ICAM-1和CD68的mRNA的表达水平较低。研究人员得出结论:我们的研究数据显示基底细胞癌的风险与早期生活压力有关

doi:10.1001/archgenpsychiatry.2011.1535
PMC:
PMID:

NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function

Christopher P. Fagundes, PhD; Ronald Glaser, PhD; Sheri L. Johnson, PhD; Rebecca R. Andridge, PhD; Eric V. Yang, PhD; Michael P. Di Gregorio, MS; Min Chen, MS; David R. Lambert, MD; Scott D. Jewell, MD; Mark A. Bechtel, MD; Dean W. Hearne, MD; Joel B. Herron, MD; Janice K. Kiecolt-Glaser, PhD

Context Child emotional maltreatment can result in lasting immune dysregulation that may be heightened in the context of more recent life stress. Basal cell carcinoma (BCC) is the most common skin cancer, and the immune system plays a prominent role in tumor appearance and progression.

Objective To address associations among recent severe life events, childhood parental emotional maltreatment, depression, and messenger RNA (mRNA) coding for immune markers associated with BCC tumor progression and regression.

Design We collected information about early parent-child experiences, severe life events in the past year as assessed by the Life Events and Difficulties Schedule, depression, and mRNA for immune markers associated with BCC tumor progression and regression from patients with BCC tumors.

Setting University medical center.

Participants Ninety-one patients with BCC (ages, 23-92 years) who had a previous BCC tumor.

Main Outcome Measures The expression of 4 BCC tumor mRNA markers (CD25, CD3ϵ, intercellular adhesion molecule 1, and CD68) that have been linked to BCC tumor progression and regression were assessed in BCC tumor biopsy specimens.

Results Both maternal and paternal emotional maltreatment interacted with the occurrence of severe life events to predict the local immune response to the tumor (adjusted P = .009 and P = .03, respectively). Among BCC patients who had experienced a severe life event within the past year, those who were emotionally maltreated by their mothers (P = .007) or fathers (P = .02) as children had a poorer immune response to the BCC tumor. Emotional maltreatment was unrelated to BCC immune responses among those who did not experience a severe life event. Depressive symptoms were not associated with the local tumor immune response.

Conclusions Troubled early parent-child relationships, in combination with a severe life event in the past year, predicted immune responses to a BCC tumor. The immunoreactivity observed in BCCs and the surrounding stroma reflects an anti–tumor-specific immune response that can be altered by stress.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061324, encodeId=cccb2061324f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jan 28 05:03:00 CST 2013, time=2013-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994065, encodeId=383c1994065a4, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Jul 10 08:03:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791822, encodeId=f5fc1e9182219, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Sep 28 04:03:00 CST 2012, time=2012-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978323, encodeId=e13919e8323fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Apr 04 21:03:00 CST 2013, time=2013-04-04, status=1, ipAttribution=)]
    2013-01-28 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061324, encodeId=cccb2061324f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jan 28 05:03:00 CST 2013, time=2013-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994065, encodeId=383c1994065a4, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Jul 10 08:03:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791822, encodeId=f5fc1e9182219, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Sep 28 04:03:00 CST 2012, time=2012-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978323, encodeId=e13919e8323fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Apr 04 21:03:00 CST 2013, time=2013-04-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061324, encodeId=cccb2061324f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jan 28 05:03:00 CST 2013, time=2013-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994065, encodeId=383c1994065a4, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Jul 10 08:03:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791822, encodeId=f5fc1e9182219, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Sep 28 04:03:00 CST 2012, time=2012-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978323, encodeId=e13919e8323fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Apr 04 21:03:00 CST 2013, time=2013-04-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061324, encodeId=cccb2061324f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jan 28 05:03:00 CST 2013, time=2013-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994065, encodeId=383c1994065a4, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Jul 10 08:03:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791822, encodeId=f5fc1e9182219, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Sep 28 04:03:00 CST 2012, time=2012-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978323, encodeId=e13919e8323fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Apr 04 21:03:00 CST 2013, time=2013-04-04, status=1, ipAttribution=)]

相关资讯

FDA:皮肤基底细胞癌新药Erivedge获批

 2012年1月30日,美国食品与药物管理局(FDA)批准Erivedge(vismodegib)用于治疗成人最常见的皮肤癌——基底细胞癌。该药预期用于不能手术或放疗的局部晚期皮肤基底细胞癌患者和肿瘤已转移的患者。   Erivedge经由优先审查程序获准,是FDA批准的首个治疗转移性基底细胞癌的药物。它通过抑制Hedgehog通路起效,这种通路在大多数基底细胞癌中活跃,但仅在少许正常组织中(

NEJM:Vismodegib被证明对基底细胞癌有效

根据6月6日《新英格兰医学杂志》发表的两项小型早期研究结果,vismodegib可有效治疗基底细胞痣综合征和进展期基底细胞癌(BCC)。 基底细胞恶性肿瘤在美国是最常见的非黑色素瘤皮肤癌之一,在210万例患者中占80%以上。这是一种严重破坏容貌的癌症,但较少危及生命。几乎所有的BCC都由hedgehog信号传导通路的改变所致。美国食品药品管理局(FDA)今年1月份批准了Vismodegib用于治疗

头颈部皮肤癌切缘阳性患者或可选择临床观察

 据美国耳鼻喉医师协会联合会议上报告的一项回顾性研究结果,头颈部皮肤癌切缘阳性患者除选择再切除术之外,观察或“观察等待”也是一种可接受的选择。 为比较头颈部皮肤癌切缘阳性患者观察等待与再切除的预后情况,西弗吉尼亚州摩根顿克拉克斯堡美国退伍军人医院的Justin Douglas博士及其同事对492例患者进行回顾性研究。患者均在5年前接受头颈部皮肤癌切除术,包括387例基底细胞癌(B